Restoration Robotics (NASDAQ:HAIR) and Silk Road Medical (NASDAQ:SILK) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, analyst recommendations and risk.
This is a summary of recent recommendations for Restoration Robotics and Silk Road Medical, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Silk Road Medical||0||0||3||0||3.00|
Silk Road Medical has a consensus price target of $49.67, indicating a potential upside of 24.85%. Given Silk Road Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Silk Road Medical is more favorable than Restoration Robotics.
Volatility and Risk
Restoration Robotics has a beta of 4.26, indicating that its share price is 326% more volatile than the S&P 500. Comparatively, Silk Road Medical has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.
Valuation & Earnings
This table compares Restoration Robotics and Silk Road Medical’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Restoration Robotics||$21.96 million||7.96||-$28.73 million||($0.86)||-4.98|
|Silk Road Medical||$63.35 million||19.76||-$52.42 million||($1.36)||-29.25|
Restoration Robotics has higher earnings, but lower revenue than Silk Road Medical. Silk Road Medical is trading at a lower price-to-earnings ratio than Restoration Robotics, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
17.6% of Restoration Robotics shares are held by institutional investors. Comparatively, 98.3% of Silk Road Medical shares are held by institutional investors. 37.8% of Restoration Robotics shares are held by insiders. Comparatively, 7.8% of Silk Road Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
This table compares Restoration Robotics and Silk Road Medical’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Silk Road Medical||-54.94%||-44.17%||-24.11%|
Silk Road Medical beats Restoration Robotics on 9 of the 14 factors compared between the two stocks.
Restoration Robotics Company Profile
Restoration Robotics, Inc., a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. The company offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites. Its system includes the ARTAS Hair Studio application, an interactive three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. The company was founded in 2002 and is headquartered in San Jose, California.
Silk Road Medical Company Profile
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.
Receive News & Ratings for Restoration Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Restoration Robotics and related companies with MarketBeat.com's FREE daily email newsletter.